BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanazawa M, Palsson OS, Thiwan SI, Turner MJ, van Tilburg MA, Gangarosa LM, Chitkara DK, Fukudo S, Drossman DA, Whitehead WE. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol. 2008;103:2550-2561. [PMID: 18684175 DOI: 10.1111/j.1572-0241.2008.02066.x] [Cited by in Crossref: 103] [Cited by in F6Publishing: 91] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Fukudo S, Kaneko H, Akiho H, Inamori M, Endo Y, Okumura T, Kanazawa M, Kamiya T, Sato K, Chiba T, Furuta K, Yamato S, Arakawa T, Fujiyama Y, Azuma T, Fujimoto K, Mine T, Miura S, Kinoshita Y, Sugano K, Shimosegawa T. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015;50:11-30. [PMID: 25500976 DOI: 10.1007/s00535-014-1017-0] [Cited by in Crossref: 78] [Cited by in F6Publishing: 66] [Article Influence: 9.8] [Reference Citation Analysis]
2 Annaházi A, Róka R, Rosztóczy A, Wittmann T. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol 2014; 20(20): 6031-6043 [PMID: 24876726 DOI: 10.3748/wjg.v20.i20.6031] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 6.1] [Reference Citation Analysis]
3 Melchior C, Gourcerol G, Chastan N, Verin E, Menard JF, Ducrotte P, Leroi AM. Effect of transcranial magnetic stimulation on rectal sensitivity in irritable bowel syndrome: a randomized, placebo-controlled pilot study. Colorectal Dis. 2014;16:O104-O111. [PMID: 24119239 DOI: 10.1111/codi.12450] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
4 Simrén M, Törnblom H, Palsson OS, Van Oudenhove L, Whitehead WE, Tack J. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology 2019;157:391-402.e2. [PMID: 31022401 DOI: 10.1053/j.gastro.2019.04.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
5 Fukudo S. Stress and visceral pain: focusing on irritable bowel syndrome. Pain. 2013;154 Suppl 1:S63-S70. [PMID: 24021863 DOI: 10.1016/j.pain.2013.09.008] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
6 Kanazawa M, Hamaguchi T, Watanabe S, Terui T, Mine H, Kano M, Fukudo S. Site-specific differences in central processing of visceral stimuli from the rectum and the descending colon in men. Neurogastroenterol Motil 2010;22:173-80, e53. [PMID: 19825012 DOI: 10.1111/j.1365-2982.2009.01417.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
7 Whitehead WE, Palsson OS, Gangarosa L, Turner M, Tucker J. Lubiprostone does not influence visceral pain thresholds in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2011;23:944-e400. [PMID: 21914041 DOI: 10.1111/j.1365-2982.2011.01776.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
8 Shin SY, Cha BK, Kim WS, Park JY, Kim JW, Choi CH. The Effect of Phloroglucinol in Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled Trial. J Neurogastroenterol Motil 2020;26:117-27. [PMID: 31917916 DOI: 10.5056/jnm19160] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
9 Tack J, Corsetti M, Camilleri M, Quigley EM, Simren M, Suzuki H, Talley NJ, Tornblom H, Van Oudenhove L. Plausibility criteria for putative pathophysiological mechanisms in functional gastrointestinal disorders: a consensus of experts. Gut 2018;67:1425-33. [DOI: 10.1136/gutjnl-2016-312230] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Keszthelyi D, Troost FJ, Masclee AA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Methods to assess visceral hypersensitivity in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2012;303:G141-G154. [PMID: 22595988 DOI: 10.1152/ajpgi.00060.2012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 8.5] [Reference Citation Analysis]
11 Becker-Dreps S, Morgan D, Peña R, Cortes L, Martin CF, Valladares E. Association between intimate partner violence and irritable bowel syndrome: a population-based study in Nicaragua. Violence Against Women 2010;16:832-45. [PMID: 20558772 DOI: 10.1177/1077801210374816] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
12 Sheehan J, Gaman A, Vangel M, Kuo B. Pooled analysis of brain activity in irritable bowel syndrome and controls during rectal balloon distension. Neurogastroenterol Motil 2011;23:336-46, e158. [PMID: 21118328 DOI: 10.1111/j.1365-2982.2010.01635.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
13 Gallego D, Aulí M, Aleu J, Martínez E, Rofes L, Martí-Ragué J, Jiménez M, Clavé P. Effect of otilonium bromide on contractile patterns in the human sigmoid colon. Neurogastroenterol Motil 2010;22:e180-91. [PMID: 20367799 DOI: 10.1111/j.1365-2982.2010.01495.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhao C, Qi L, Wu L, Yi T, Wu H, Guo X, Zhou C, Liu H, Wang X. Suspended moxibustion at Tianshu (ST25) inhibits prokineticin 1 and prokineticin receptor 1 expression in the spinal cord of rats with chronic visceral hypersensitivity. Neural Regen Res 2012;7:1145-50. [PMID: 25722707 DOI: 10.3969/j.issn.1673-5374.2012.15.004] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
15 Zhou TR, Huang JJ, Huang ZT, Cao HY, Tan B. Inhibitory effects of patchouli alcohol on stress-induced diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2018; 24(6): 693-705 [PMID: 29456408 DOI: 10.3748/wjg.v24.i6.693] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
16 Quigley EM. What we have learned about colonic motility: normal and disturbed. Curr Opin Gastroenterol 2010;26:53-60. [PMID: 19786868 DOI: 10.1097/MOG.0b013e328332c977] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
17 El-Salhy M, Gundersen D, Gilja OH, Hatlebakk JG, Hausken T. Is irritable bowel syndrome an organic disorder? World J Gastroenterol 2014; 20(2): 384-400 [PMID: 24574708 DOI: 10.3748/wjg.v20.i2.384] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
18 Carroll IM, Ringel-Kulka T, Ferrier L, Wu MC, Siddle JP, Bueno L, Ringel Y. Fecal protease activity is associated with compositional alterations in the intestinal microbiota. PLoS One. 2013;8:e78017. [PMID: 24147109 DOI: 10.1371/journal.pone.0078017] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
19 Duracinsky M, Chassany O. [How can an effective drug to treat irritable bowel syndrome be successfully developed?]. Gastroenterol Clin Biol 2009;33 Suppl 1:S26-34. [PMID: 19303535 DOI: 10.1016/S0399-8320(09)71522-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Meerveld BG, Johnson AC. Mechanisms of Stress-induced Visceral Pain. J Neurogastroenterol Motil 2018;24:7-18. [PMID: 29291604 DOI: 10.5056/jnm17137] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
21 Romero P, Schmitteckert S, Wouters MM, Houghton LA, Czogalla B, Sayuk GS, Boeckxstaens GE, Guenther P, Holland-Cunz S, Niesler B. No association between the common calcium-sensing receptor polymorphism rs1801725 and irritable bowel syndrome. BMC Med Genet 2015;16:110. [PMID: 26654249 DOI: 10.1186/s12881-015-0256-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Wang YT, Xu WX. Role of stress in pathophysiology of irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2018; 26(17): 1064-1070 [DOI: 10.11569/wcjd.v26.i17.1064] [Reference Citation Analysis]
23 Mari A, Sbeit W, Pellicano R, Khoury T. The interplay between pancreatic enzymes insufficiency and irritable bowel syndrome. Minerva Gastroenterol (Torino) 2021;67:173-4. [PMID: 34027934 DOI: 10.23736/S2724-5985.20.02800-7] [Reference Citation Analysis]
24 Qi Q, Chen F, Zhang W, Wang P, Li Y, Zuo X. Colonic N-methyl-d-aspartate receptor contributes to visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2017;32:828-836. [PMID: 27575648 DOI: 10.1111/jgh.13588] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
25 Layer P, Andresen V, Allescher H, Bischoff SC, Claßen M, Elsenbruch S, Freitag M, Frieling T, Gebhard M, Goebel-Stengel M, Häuser W, Holtmann G, Keller J, Kreis ME, Kruis W, Langhorst J, Jansen PL, Madisch A, Mönnikes H, Müller-Lissner S, Niesler B, Pehl C, Pohl D, Raithel M, Röhrig-Herzog G, Schemann M, Schmiedel S, Schwille-Kiuntke J, Storr M, Preiß JC, Andus T, Buderus S, Ehlert U, Engel M, Enninger A, Fischbach W, Gillessen A, Gschossmann J, Gundling F, Haag S, Helwig U, Hollerbach S, Karaus M, Katschinski M, Krammer H, Kuhlbusch-Zicklam R, Matthes H, Menge D, Miehlke S, Posovszky MC, Schaefert R, Schmidt-Choudhury A, Schwandner O, Schweinlin A, Seidl H, Stengel A, Tesarz J, van der Voort I, Voderholzer W, von Boyen G, von Schönfeld J, Wedel T; Collaborators:., in Zusammenarbeit mit:., Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin (DEGAM)., Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)., Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV)., Deutsche Gesellschaft für Ernährungsmedizin (DGEM)., Deutsche Gesellschaft für Geriatrie (DGG)., Deutsche Gesellschaft für Innere Medizin (DGIM)., Deutsche Gesellschaft für Naturheilkunde (DGNHK)., Deutsche Gesellschaft für Pathologie und Bundesverband deutscher Pathologen e. V. (DGP/BDP)., Deutsche Gesellschaft für Psychosomatische Medizin und Ärztliche Psychotherapie (DGPM)., Deutsche Gesellschaft für Verhaltensmedizin und Verhaltensmodifikation (DGVM)., Deutsche Schmerzgesellschaft e. V., Deutsches Kollegium für Psychosomatische Medizin (DKPM), Deutsche Gesellschaft für Tropenmedizin und Internationale Gesundheit (DTG)., Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE)., Deutschen Gesellschaft für Kinder- und Jugendmedizin (DGKJ)., Swiss Society of Neurogastroenterology and Motility (SwissNGM)., Informationsforum für Patient:innen mit Magen-Darm-Erkrankungen (MAGDA). Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016. Z Gastroenterol 2021;59:1323-415. [PMID: 34891206 DOI: 10.1055/a-1591-4794] [Reference Citation Analysis]
26 El-Salhy M. Recent advances in the diagnosis of irritable bowel syndrome. Expert Rev Gastroenterol Hepatol 2015;9:1161-74. [PMID: 26162959 DOI: 10.1586/17474124.2015.1067138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
27 Clavé P. Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets. Neurogastroenterol Motil. 2011;23:1051-1055. [PMID: 22093116 DOI: 10.1111/j.1365-2982.2011.01808.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
28 Perna E, Aguilera-Lizarraga J, Florens MV, Jain P, Theofanous SA, Hanning N, De Man JG, Berg M, De Winter B, Alpizar YA, Talavera K, Vanden Berghe P, Wouters M, Boeckxstaens G. Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS. Gut. 2020 epub ahead of print. [PMID: 33023902 DOI: 10.1136/gutjnl-2020-321530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Clarke G, Quigley EM, Cryan JF, Dinan TG. Irritable bowel syndrome: towards biomarker identification. Trends Mol Med. 2009;15:478-489. [PMID: 19811951 DOI: 10.1016/j.molmed.2009.08.001] [Cited by in Crossref: 111] [Cited by in F6Publishing: 114] [Article Influence: 8.5] [Reference Citation Analysis]
30 Van Oudenhove L, Crowell MD, Drossman DA, Halpert AD, Keefer L, Lackner JM, Murphy TB, Naliboff BD, Levy RL. Biopsychosocial Aspects of Functional Gastrointestinal Disorders. Gastroenterology. 2016;S0016-5085:27144624. [PMID: 27144624 DOI: 10.1053/j.gastro.2016.02.027] [Cited by in Crossref: 173] [Cited by in F6Publishing: 103] [Article Influence: 28.8] [Reference Citation Analysis]
31 Farzaei MH, Bahramsoltani R, Abdollahi M, Rahimi R. The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil. 2016;22:558-574. [PMID: 27431236 DOI: 10.5056/jnm16001] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 12.8] [Reference Citation Analysis]
32 Törnblom H, Van Oudenhove L, Tack J, Simrén M. Interaction between preprandial and postprandial rectal sensory and motor abnormalities in IBS. Gut. 2014;63:1441-1449. [PMID: 24142965 DOI: 10.1136/gutjnl-2013-305853] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
33 Jia M, Lu X, Wang Z, Zhao L, Zhang S. Effects of Fengliao-Changweikang in Diarrhea-predominant Irritable Bowel Syndrome Rats and Its Mechanism Involving Colonic Motility. J Neurogastroenterol Motil 2018;24:479-89. [PMID: 29715711 DOI: 10.5056/jnm17093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
34 Simrén M, Palsson OS, Heymen S, Bajor A, Törnblom H, Whitehead WE. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients. Neurogastroenterol Motil 2017;29. [PMID: 27581702 DOI: 10.1111/nmo.12919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
35 MacLean EW, Palsson OS, Turner MJ, Whitehead WE. Development and validation of new disease-specific measures of somatization and comorbidity in IBS. J Psychosom Res. 2012;73:351-355. [PMID: 23062808 DOI: 10.1016/j.jpsychores.2012.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
36 Ludidi S, Conchillo JM, Keszthelyi D, Koning CJ, Vanhoutvin SA, Lindsey PJ, Leufkens AM, Kruimel JW, Jonkers DM, Masclee AA. Does meal ingestion enhance sensitivity of visceroperception assessment in irritable bowel syndrome? Neurogastroenterol Motil 2012;24:47-53, e3. [PMID: 22050206 DOI: 10.1111/j.1365-2982.2011.01802.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
37 Fukudo S, Kinoshita Y, Okumura T, Ida M, Akiho H, Nakashima Y, Nishida A, Haruma K. Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women. Gastroenterology. 2016;150:358-366.e8. [PMID: 26551550 DOI: 10.1053/j.gastro.2015.10.047] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 8.9] [Reference Citation Analysis]
38 Zhou Q, Fillingim RB, Riley III JL, Verne GN. Thermal hypersensitivity in a subset of irritable bowel syndrome patients. World J Gastroenterol 2009; 15(26): 3254-3260 [PMID: 19598301 DOI: 10.3748/wjg.15.3254] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
39 Bennet SMP, Palsson O, Whitehead WE, Barrow DA, Törnblom H, Öhman L, Simrén M, van Tilburg MAL. Systemic cytokines are elevated in a subset of patients with irritable bowel syndrome but largely unrelated to symptom characteristics. Neurogastroenterol Motil 2018;30:e13378. [PMID: 29797382 DOI: 10.1111/nmo.13378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
40 Sakakibara R, Katsuragawa S. Voiding and storage symptoms in depression/anxiety. Auton Neurosci 2022;237:102927. [PMID: 34923228 DOI: 10.1016/j.autneu.2021.102927] [Reference Citation Analysis]
41 Tanaka Y, Kanazawa M, Palsson OS, Tilburg MAV, Gangarosa LM, Fukudo S, Drossman DA, Whitehead WE. Increased Postprandial Colonic Motility and Autonomic Nervous System Activity in Patients With Irritable Bowel Syndrome: A Prospective Study. J Neurogastroenterol Motil. 2018;24:87-95. [PMID: 29291610 DOI: 10.5056/jnm16216] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
42 Rey de Castro NG, Miller V, Carruthers HR, Whorwell PJ. Irritable bowel syndrome: a comparison of subtypes. J Gastroenterol Hepatol. 2015;30:279-285. [PMID: 25091059 DOI: 10.1111/jgh.12704] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
43 Okumura T, Nozu T, Kumei S, Takakusaki K, Miyagishi S, Ohhira M. Antinociceptive action against colonic distension by brain orexin in conscious rats. Brain Research 2015;1598:12-7. [DOI: 10.1016/j.brainres.2014.12.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
44 Ludidi S, Conchillo JM, Keszthelyi D, Van Avesaat M, Kruimel JW, Jonkers DM, Masclee AA. Rectal hypersensitivity as hallmark for irritable bowel syndrome: defining the optimal cutoff. Neurogastroenterol Motil. 2012;24:729-33, e345-6. [PMID: 22591192 DOI: 10.1111/j.1365-2982.2012.01926.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
45 Heitkemper M, Cain KC, Shulman R, Burr R, Poppe A, Jarrett M. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern. Dig Dis Sci 2011;56:2050-8. [PMID: 21290181 DOI: 10.1007/s10620-011-1567-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
46 Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. The Microbiome and Irritable Bowel Syndrome - A Review on the Pathophysiology, Current Research and Future Therapy. Front Microbiol. 2019;10:1136. [PMID: 31244784 DOI: 10.3389/fmicb.2019.01136] [Cited by in Crossref: 60] [Cited by in F6Publishing: 56] [Article Influence: 20.0] [Reference Citation Analysis]
47 Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD. Overlapping Chronic Pain Conditions: Implications for Diagnosis and Classification. J Pain 2016;17:T93-T107. [PMID: 27586833 DOI: 10.1016/j.jpain.2016.06.002] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 29.8] [Reference Citation Analysis]
48 Leung WW, Jones AY, Ng SS, Wong CY, Lee JF. Acupuncture transcutaneous electrical nerve stimulation reduces discomfort associated with barostat-induced rectal distension: A randomized-controlled study. World J Gastroenterol 2013; 19(3): 381-388 [PMID: 23372361 DOI: 10.3748/wjg.v19.i3.381] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
49 Kanazawa M, Palsson OS, van Tilburg MA, Gangarosa LM, Fukudo S, Whitehead WE. Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS). Neurogastroenterol Motil. 2014;26:696-704. [PMID: 24602083 DOI: 10.1111/nmo.12318] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
50 Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014;49:1193-1205. [PMID: 24845149 DOI: 10.1007/s00535-014-0966-7] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
51 Zhang Y, Qin G, Liu DR, Wang Y, Yao SK. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome. World J Gastroenterol 2019; 25(2): 269-281 [PMID: 30670915 DOI: 10.3748/wjg.v25.i2.269] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
52 Mavroudis G, Strid H, Jonefjäll B, Simrén M. Visceral hypersensitivity is together with psychological distress and female gender associated with severity of IBS-like symptoms in quiescent ulcerative colitis. Neurogastroenterol Motil 2021;33:e13998. [PMID: 33034406 DOI: 10.1111/nmo.13998] [Reference Citation Analysis]
53 Sarna SK. Colonic Motility: From Bench Side to Bedside. Colloquium Series on Integrated Systems Physiology: From Molecule to Function 2010;2:1-157. [DOI: 10.4199/c00020ed1v01y201011isp011] [Cited by in Crossref: 11] [Article Influence: 0.9] [Reference Citation Analysis]
54 Ida M, Nishida A, Akiho H, Nakashima Y, Matsueda K, Fukudo S. Evaluation of the irritable bowel syndrome severity index in Japanese male patients with irritable bowel syndrome with diarrhea. Biopsychosoc Med 2017;11:7. [PMID: 28293280 DOI: 10.1186/s13030-017-0092-x] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
55 Clavé P, Acalovschi M, Triantafillidis JK, Uspensky YP, Kalayci C, Shee V, Tack J. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome. Aliment Pharmacol Ther. 2011;34:432-442. [PMID: 21679214 DOI: 10.1111/j.1365-2036.2011.04730.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 6.5] [Reference Citation Analysis]
56 Mujagic Z, Keszthelyi D, Aziz Q, Reinisch W, Quetglas EG, De Leonardis F, Segerdahl M, Masclee AA. Systematic review: instruments to assess abdominal pain in irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:1064-81. [PMID: 26290286 DOI: 10.1111/apt.13378] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
57 Tremolaterra F, Gallotta S, Morra Y, Lubrano E, Ciacci C, Iovino P. The severity of irritable bowel syndrome or the presence of fibromyalgia influencing the perception of visceral and somatic stimuli. BMC Gastroenterol 2014;14:182. [PMID: 25323092 DOI: 10.1186/1471-230X-14-182] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
58 Del Valle-Pinero AY, Sherwin LB, Anderson EM, Caudle RM, Henderson WA. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis. World J Gastroenterol 2015; 21(1): 155-163 [PMID: 25574088 DOI: 10.3748/wjg.v21.i1.155] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
59 Lu J, Shi L, Huang D, Fan W, Li X, Zhu L, Wei J, Fang X. Depression and Structural Factors Are Associated With Symptoms in Patients of Irritable Bowel Syndrome With Diarrhea. J Neurogastroenterol Motil 2020;26:505-13. [PMID: 32675388 DOI: 10.5056/jnm19166] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Kanazawa M, Miwa H, Nakagawa A, Kosako M, Akiho H, Fukudo S. Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan. Biopsychosoc Med 2016;10:19. [PMID: 27274765 DOI: 10.1186/s13030-016-0070-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
61 Rangan V, Singh P, Ballou S, Hassan R, Yu V, Katon J, Nee J, Iturrino J, Lembo A. Improvement in constipation and diarrhea is associated with improved abdominal pain in patients with functional bowel disorders. Neurogastroenterol Motil 2021;:e14253. [PMID: 34520617 DOI: 10.1111/nmo.14253] [Reference Citation Analysis]
62 Hearn M, Whorwell PJ, Vasant DH. Stigma and irritable bowel syndrome: a taboo subject? The Lancet Gastroenterology & Hepatology 2020;5:607-15. [DOI: 10.1016/s2468-1253(19)30348-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 2] [Article Influence: 7.5] [Reference Citation Analysis]
63 Whitehead WE, Palsson OS, Simrén M. Biomarkers to distinguish functional constipation from irritable bowel syndrome with constipation. Neurogastroenterol Motil 2016;28:783-92. [PMID: 27214096 DOI: 10.1111/nmo.12852] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
64 Kanazawa M, Hongo M, Fukudo S. Visceral hypersensitivity in irritable bowel syndrome. J Gastroenterol Hepatol. 2011;26 Suppl 3:119-121. [PMID: 21443723 DOI: 10.1111/j.1440-1746.2011.06640.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
65 van Hoboken EA, Thijssen AY, Verhaaren R, van der Veek PP, Prins FA, Verspaget HW, Masclee AA. Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity. Scand J Gastroenterol. 2011;46:981-987. [PMID: 21623672 DOI: 10.3109/00365521.2011.579156] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 3.8] [Reference Citation Analysis]
66 Gunnarsson J, Simrén M. Peripheral factors in the pathophysiology of irritable bowel syndrome. Dig Liver Dis. 2009;41:788-793. [PMID: 19665956 DOI: 10.1016/j.dld.2009.07.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 2.4] [Reference Citation Analysis]
67 Okawa Y. Development of colonic transit time and ultrasound imaging tools as objective indicators for assessing abnormal defecation associated with food intake: a narrative review based on previous scientific knowledge. Biopsychosoc Med 2021;15:20. [PMID: 34742336 DOI: 10.1186/s13030-021-00222-1] [Reference Citation Analysis]
68 Vanhoutvin SA, Troost FJ, Kilkens TO, Lindsey PJ, Jonkers DM, Venema K, Masclee A, Brummer RJ. Alternative procedure to shorten rectal barostat procedure for the assessment of rectal compliance and visceral perception: a feasibility study. J Gastroenterol 2012;47:896-903. [PMID: 22361864 DOI: 10.1007/s00535-012-0543-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
69 van Tilburg MA, Palsson OS, Whitehead WE. Which psychological factors exacerbate irritable bowel syndrome? Development of a comprehensive model. J Psychosom Res. 2013;74:486-492. [PMID: 23731745 DOI: 10.1016/j.jpsychores.2013.03.004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 7.4] [Reference Citation Analysis]
70 Vlieger AM, van den Berg MM, Menko-Frankenhuis C, Bongers ME, Tromp E, Benninga MA. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome. Am J Gastroenterol 2010;105:213-8. [PMID: 19861956 DOI: 10.1038/ajg.2009.613] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
71 Zhang L, Wang R, Bai T, Xiang X, Qian W, Song J, Hou X. EphrinB2/ephB2-mediated myenteric synaptic plasticity: mechanisms underlying the persistent muscle hypercontractility and pain in postinfectious IBS. FASEB J 2019;33:13644-59. [PMID: 31601124 DOI: 10.1096/fj.201901192R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
72 Sato N, Suzuki N, Sasaki A, Aizawa E, Obayashi T, Kanazawa M, Mizuno T, Kano M, Aoki M, Fukudo S. Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome. PLoS One. 2012;7:e42450. [PMID: 22957021 DOI: 10.1371/journal.pone.0042450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
73 Zhou C, Zhao J, Wu L, Huang R, Shi Y, Wang X, Liao W, Hong J, Liu S, Wu H. Mild moxibustion decreases the expression of prokineticin 2 and prokineticin receptor 2 in the colon and spinal cord of rats with irritable bowel syndrome. Evid Based Complement Alternat Med 2014;2014:807308. [PMID: 25024732 DOI: 10.1155/2014/807308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
74 Clavé P, Tack J. Efficacy of otilonium bromide in irritable bowel syndrome: a pooled analysis. Therap Adv Gastroenterol 2017;10:311-22. [PMID: 28246548 DOI: 10.1177/1756283X16681708] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Okumura T, Ishioh M, Nozu T. Central regulatory mechanisms of visceral sensation in response to colonic distension with special reference to brain orexin. Neuropeptides 2021;86:102129. [PMID: 33636498 DOI: 10.1016/j.npep.2021.102129] [Reference Citation Analysis]
76 Kennedy PJ, Clarke G, Quigley EM, Groeger JA, Dinan TG, Cryan JF. Gut memories: towards a cognitive neurobiology of irritable bowel syndrome. Neurosci Biobehav Rev. 2012;36:310-340. [PMID: 21777613 DOI: 10.1016/j.neubiorev.2011.07.001] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 9.4] [Reference Citation Analysis]
77 LeBrett WG, Chen FW, Yang L, Chang L. Increasing Rates of Opioid Prescriptions for Gastrointestinal Diseases in the United States. Am J Gastroenterol 2021;116:796-807. [PMID: 33982950 DOI: 10.14309/ajg.0000000000001052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Yang CQ, Wei YY, Leng YX, Zhong CJ, Zhang YS, Wan Y, Duan LP. Vesicular glutamate transporter-3 contributes to visceral hyperalgesia induced by Trichinella spiralis infection in rats. Dig Dis Sci. 2012;57:865-872. [PMID: 22160634 DOI: 10.1007/s10620-011-1970-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
79 Fritzell K, Eriksson LE, Björk J, Hultcrantz R, Wettergren L. Self-reported abdominal symptoms in relation to health status in adult patients with familial adenomatous polyposis. Dis Colon Rectum 2011;54:863-9. [PMID: 21654254 DOI: 10.1007/DCR.0b013e3182147fbe] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Eom S, Lee J, Baek YB, Yeom HD, Lee S, Kim C, Park Y, Park SI, Lee CM, Lee JH. Identification and molecular study on the interaction of Schisandrin C with human 5-HT3A receptor. Eur J Pharmacol 2021;906:174220. [PMID: 34081905 DOI: 10.1016/j.ejphar.2021.174220] [Reference Citation Analysis]
81 Hasler WL. Traditional thoughts on the pathophysiology of irritable bowel syndrome. Gastroenterol Clin North Am. 2011;40:21-43. [PMID: 21333899 DOI: 10.1016/j.gtc.2010.12.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
82 Midenfjord I, Polster A, Sjövall H, Friberg P, Törnblom H, Simrén M. Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms. Sci Rep 2020;10:9794. [PMID: 32555219 DOI: 10.1038/s41598-020-66558-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
83 Lambarth A, Zarate-Lopez N, Fayaz A. Oral and parenteral anti-neuropathic agents for the management of pain and discomfort in irritable bowel syndrome: A systematic review and meta-analysis. Neurogastroenterol Motil 2021;:e14289. [PMID: 34755926 DOI: 10.1111/nmo.14289] [Reference Citation Analysis]
84 Lu Y, Huang J, Zhang Y, Huang Z, Yan W, Zhou T, Wang Z, Liao L, Cao H, Tan B. Therapeutic Effects of Berberine Hydrochloride on Stress-Induced Diarrhea-Predominant Irritable Bowel Syndrome Rats by Inhibiting Neurotransmission in Colonic Smooth Muscle. Front Pharmacol 2021;12:596686. [PMID: 34594213 DOI: 10.3389/fphar.2021.596686] [Reference Citation Analysis]
85 Ida M, Nishida A, Akiho H, Nakashima Y, Matsueda K, Fukudo S. Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea. Biopsychosoc Med 2017;11:8. [PMID: 28331539 DOI: 10.1186/s13030-017-0093-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
86 Li L, Dong L, Wang S. Expression of the nociceptin/orphanin FQ receptor in the intestinal mucosa of IBS patients. Exp Ther Med 2013;6:679-83. [PMID: 24137246 DOI: 10.3892/etm.2013.1186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
87 Cipriani G, Santicioli P, Evangelista S, Maggi CA, Riccadonna S, Ringressi MN, Bechi P, Faussone-Pellegrini MS, Vannucchi MG. Effect of otilonium bromide and ibodutant on the internalization of the NK2 receptor in human colon. Neurogastroenterol Motil 2011;23:96-102, e10. [PMID: 20879991 DOI: 10.1111/j.1365-2982.2010.01594.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
88 Thabane M, Simunovic M, Akhtar-Danesh N, Marshall JK. Development and validation of a risk score for post-infectious irritable bowel syndrome. Am J Gastroenterol 2009;104:2267-74. [PMID: 19568228 DOI: 10.1038/ajg.2009.302] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
89 Okuyama Y, Okamoto T, Sasaki D, Ozaki K, Songee J, Hatakeyama S, Mikami T, Ohyama C. The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan. Int Urol Nephrol 2021. [PMID: 34714460 DOI: 10.1007/s11255-021-03044-w] [Reference Citation Analysis]
90 Stabell N, Stubhaug A, Flægstad T, Nielsen CS. Increased pain sensitivity among adults reporting irritable bowel syndrome symptoms in a large population-based study. Pain 2013;154:385-92. [DOI: 10.1016/j.pain.2012.11.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
91 Simrén M, Törnblom H, Palsson OS, van Tilburg MAL, Van Oudenhove L, Tack J, Whitehead WE. Visceral hypersensitivity is associated with GI symptom severity in functional GI disorders: consistent findings from five different patient cohorts. Gut 2018;67:255-62. [DOI: 10.1136/gutjnl-2016-312361] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 19.6] [Reference Citation Analysis]
92 Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, Sato K, Shiotani A, Naito Y, Fujikawa Y, Hokari R, Masaoka T, Fujimoto K, Kaneko H, Torii A, Matsueda K, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol 2021;56:193-217. [PMID: 33538894 DOI: 10.1007/s00535-020-01746-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K. Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2014;12:953-959.e4. [PMID: 24315882 DOI: 10.1016/j.cgh.2013.11.024] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
94 Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin. Gastroenterology. 2013;145:749-757; quiz e13-4. [PMID: 23872499 DOI: 10.1053/j.gastro.2013.07.014] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 8.6] [Reference Citation Analysis]
95 Komuro H, Sato N, Sasaki A, Suzuki N, Kano M, Tanaka Y, Yamaguchi-Kabata Y, Kanazawa M, Warita H, Aoki M, Fukudo S. Corticotropin-Releasing Hormone Receptor 2 Gene Variants in Irritable Bowel Syndrome. PLoS One 2016;11:e0147817. [PMID: 26808377 DOI: 10.1371/journal.pone.0147817] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
96 Hasler WL, Saad RJ, Rao SS, Wilding GE, Parkman HP, Koch KL, McCallum RW, Kuo B, Sarosiek I, Sitrin MD. Heightened colon motor activity measured by a wireless capsule in patients with constipation: relation to colon transit and IBS. Am J Physiol Gastrointest Liver Physiol. 2009;297:G1107-G1114. [PMID: 19808653 DOI: 10.1152/ajpgi.00136.2009] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
97 Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C. Altered gut microbiome associated with overactive bladder and daily urinary urgency. World J Urol 2021;39:847-53. [PMID: 32419054 DOI: 10.1007/s00345-020-03243-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Spetalen S, Sandvik L, Blomhoff S, Jacobsen MB. Rectal visceral sensitivity in women with irritable bowel syndrome without psychiatric comorbidity compared with healthy volunteers. Gastroenterol Res Pract 2009;2009:130684. [PMID: 19789637 DOI: 10.1155/2009/130684] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
99 Jeffery P, McDonald V, Tippett E, McGuckin M. Ghrelin in gastrointestinal disease. Mol Cell Endocrinol. 2011;340:35-43. [PMID: 21458525 DOI: 10.1016/j.mce.2011.03.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
100 Sakakibara R, Ogata T, Aiba Y, Tateno F, Uchiyama T, Yamamoto T. Does Depression Contribute to the Bladder and Bowel Complaint in Parkinson's Disease Patients? Mov Disord Clin Pract 2021;8:240-4. [PMID: 33553494 DOI: 10.1002/mdc3.13124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
101 Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S. Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2011;23:754-e332. [PMID: 21615623 DOI: 10.1111/j.1365-2982.2011.01732.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]